36 results on '"Cheong, Taek-Chin"'
Search Results
2. ERα-associated translocations underlie oncogene amplifications in breast cancer
3. Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma
4. Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma
5. Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers.
6. Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers
7. The CRISPR/Cas9 System as a Tool to Engineer Chromosomal Translocation In Vivo
8. Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma
9. Assessment of Cellular Uptake Efficiency According to Multiple Inhibitors of Fe3O4-Au Core-Shell Nanoparticles: Possibility to Control Specific Endocytosis in Colorectal Cancer Cells
10. Abstract 313: Mechanisms of oncogenic tyrosine kinase fusion formation and selection in human cancers
11. Choroid plexus-CSF-targeted antioxidant therapy protects the brain from toxicity of cancer chemotherapy
12. Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells
13. Phosphatidylinositol 3-kinase blockade increases genomic instability in B cells
14. Abstract PO-50: Phophatases modulate resistance to ALK inhibitors in anaplastic large-cell lymphoma
15. Abstract 2393: APOBEC3 enzymes induce chromosomal translocations in solid cancers
16. Abstract 2400: Strong biological bias for ALK intron 19 breakpoints in NSCLC
17. Identifying Novel Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Anaplastic Large Cell Lymphoma
18. Smart Hybrid Nanocomposite for Photodynamic Inactivation of Cancer Cells with Selectivity
19. CRISPR/Cas9 Screens Reveal Multiple Layers of B cell CD40 Regulation
20. Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+anaplastic large cell lymphoma
21. Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma
22. Taurodeoxycholate Increases the Number of Myeloid-Derived Suppressor Cells That Ameliorate Sepsis in Mice
23. Abstract PR10: FBXO11 is recurrently mutated in Burkitt lymphoma and its inactivation accelerates lymphomagenesis in Eμ-myc mice
24. Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system
25. FBXO11, a Regulator of BCL6 Stability, Is Recurrently Mutated in Burkitt Lymphoma
26. PI3Kdelta Inhibitors Increase Genomic Instability By Upregulating Aid Expression
27. FBXO11 Is Recurrently Mutated in Burkitt Lymphoma and Its Inactivation Accelerates Lymphomagenesis in Eμ-Myc mice
28. Functional Manipulation of Dendritic Cells by Photoswitchable Generation of Intracellular Reactive Oxygen Species
29. Simple and Rapid In Vivo Generation of Chromosomal Rearrangements using CRISPR/Cas9 Technology
30. Synthesis of Multifunctional Fe3O4–CdSe/ZnS Nanoclusters Coated with Lipid A toward Dendritic Cell-Based Immunotherapy
31. Orientia tsutsugamushi Subverts Dendritic Cell Functions by Escaping from Autophagy and Impairing Their Migration
32. A multifunctional core–shell nanoparticle for dendritic cell-based cancer immunotherapy
33. Functional Manipulation of Dendritic Cells by Photoswitchable Generation of Intracellular Reactive Oxygen Species
34. Assessment of Cellular Uptake Efficiency According to Multiple Inhibitors of Fe3O4-Au Core-Shell Nanoparticles: Possibility to Control Specific Endocytosis in Colorectal Cancer Cells.
35. Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma
36. Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.